Tolerance and Autoimmunity: B Cells

The Autoimmune Diseases, Fourth Edition

Volumn , Issue , 2006, Pages 167-177

  Basten, Antony ^a   Brink, Robert ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78049252288     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012595961-2/50016-0     Document Type: Chapter

References (66)

1. S. Adelstein, H. Pritchard-Briscoe, R.H. Loblay and A. Basten (1990) Suppressor T cell memory. Curr. Top. Microbiol. Immunol. 159 123-138.
2. S. Akkaraju, K. Canann and C.C. Goodnow (1997) Self-reactive B cells are eliminated or inactivated by autoantigen expressed on thyroid epithelial cells. J. Exp. Med. 15 2005-2012.
3. A. Basten and C.C. Goodnow (1990) Self tolerance in T cells and B cells. M. Kendall, M. Ritter (Eds) Thymus Update 3 London: Harwood Academic 113-126.
4. A. Basten and J.F.A.P. Miller (1974) Cellular interactions in the immune response. R.P. Cox (Eds) Cell Communication Chichester: John Wiley & Sons 187-216.
5. R.E. Billingham, L. Brent and P.B. Medawar (1953) Actively acquired tolerance of foreign cells. Nature 172 603-606.
6. S. Bolland and J.V. Ravetch (2000) Spontaneous autoimmune disease in FcγRIIb-deficient mice results from strain-specific epistasis. Immunity 13 277-285.
7. P. Bretscher and M. Cohn (1970) A theory of self-nonself discrimination. Science 169 1042-1049.
8. M.J. Buchmeier, R.M. Welsh, F.J. Dutko and M.B. Oldstone (1980) The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30 275-331.
9. F.M. Burnet (1959) The Clonal Selection Theory of Acquired Immunity Nashville: Vanderbilt University Press
10. M.C. Carroll (2004) Complement system in B cell regulation. Mol. Immunol. 41 141-146.
11. P. Casali, M.T. Kasaian and G. Haughton (1994) C-1 (CD5 B) cells. A. Coutino, M.D. Kazatchkine (Eds) Autoimmunity-Physiology and Disease New York: Wiley-Liss 57-88.
12. J.M. Chiller, G.S. Habicht and W.O. Weigle (1970) Cellular sites of immunologic unresponsiveness. Proc. Natl. Acad. Sci. USA 65 551-556.
13. A.J. Coles, M. Wing, S. Smith, F. Coraddu, S. Greer, C. Taylor, A. Weetmann, G. Hale, V.K. Chatterjee, W. Waldmann and A. Compston (1999) Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354 1691-1695.
14. M.P. Cooke, A.W. Heath, K.M. Shokat, Y. Zeng, F.D. Finkelman, P.S. Linsley, M. Howard and C.C. Goodnow (1994) Immunoglobulin signal transduction guides the specificity of B cells T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179 425-438.
15. R.J. Cornall, J.G. Cyster, M.L. Hibbs, A.R. Dunn, K.L. Otipoby, E.A. Clark and C.C. Goodnow (1998) Polygenic autoimmune traits: Lyn, CD22 and SHP-1 are limiting elements of a biochemical pathway regulating BCR signalling and selection. Immunity 8 497-508.
16. G.M. Doody, P.W. Dempsey and D.T. Fearon (1996) Activation of B lymphocytes: Integrating signals from CD19, CD22 and FcγRIIb. Curr. Opin. Immunol. 8 378-382.
17. A. Ebringer, T. Rashid and C. Wilson (2003) M Zouali (Eds) Molecular mimicry as the basis of a new theory of autoimmunity Frontiers in Autoimmunity Okmsha: IOS Press 79-99.
18. J.C.W. Edwards, L. Szczepanski, J. Szechinski, A. Filipowicz-Sosnowska, P. Emery, D.R. Close, R.M. Stevens and T. Shaw (2004) Efficacy of B cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350 2572-2581.
19. P. Ehrlich and J. Morgenroth (1957) On haemolysins: Third and fifth communications. Reprinted. The Collected Papers on Paul Ehrlich vol. 2 London: Pergamon 246-255.
20. D. Gay, T. Saunders, S. Camper and M. Weigert (1993) Receptor editing: An approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177 999-1008.
21. C.C. Goodnow, J. Crosbie, S. Adelstein, T.B. Lavoie, S.J. Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wotherspoon, R.H. Loblay, K. Raphael, R.J. Trent and A. Basten (1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334 676-682.
22. C.C. Goodnow, S. Adelstein and A. Basten (1990) The need for central and peripheral tolerance in the B cell repertoire. Science 248 1373-1379.
23. C.C. Goodnow, J.G. Cyster, S.B. Hartley, S.E. Bell, M.P. Cooke, J.I. Healy, S. Akkaraju, J.C. Rathmell, S.L. Pogue and K.P. Shokat (1995) Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol. 59 279-368.
24. J.L. Gowans and E.J. Knight (1964) The route of re-circulation of lymphocytes in the rat. Proc. R. Soc. London Ser B 159 257.
25. S. Grisanti, K. Heimann and P. Wiedemann (1994) Immune response to specific molecules of the retina in proliferative vitreoretinal disorders. Graefes Arch. Clin. Exp. Ophthalmol. 232 302-307.
26. S.B. Hartley, J. Crosbie, R. Brink, A.B. Kantor, A. Basten and C.C. Goodnow (1991) Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognising membrane-bound antigens. Nature 353 765-769.
27. P.D. Hodgkin and A. Basten (1995) B cell activation, tolerance and antigen presenting function. Curr. Opin. Immunol. 7 121-129.
28. N.K. Jerne (1971) Towards a network theory of the immune system. Ann. Int. Pasteur (Paris) 125C 373-389.
29. J.E. Jun and C.C. Goodnow (2003) Scaffolding of antigen receptors for immunogenic versus tolerogenic signalling. Nat. Immunol. 4 1057-1064.
30. M.D. Kazatchkine and S.V. Kaveri (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 345 747-755.
31. K.J. Lafferty and A.J. Cunningham (1975) A new analysis of allogeneic interactions. Australas. J. Exp. Biol. Med. Sci. 53 27-42.
32. E.A. Leadbetter, I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik and A. Marshak-Rothstein (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 603-607.
33. J. Lederberg (1959) Genes and antibodies: Do antigens bear instructions for antibody specificity or do they select cell lines that arise by mutation? Science 129 1649-1653.
34. R. Lesley, Y. Zu, S.L. Kalled, D.M. Hess, S.R. Schwab, H.B. Shu and J.G. Cyster (2004) Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20 441-453.
35. H. Li, Y. Jiang, L.L. Prak, M. Radic and M. Weigert (2001) Editors and editing of anti-DNA receptors. Immunity 15 947-957.
36. F. Mackay and S.G. Tangye (2004) The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr. Opin. Pharmacol. 4 347-354.
37. V.S. Marsden and A. Strasser (2002) Control of apoptosis in the immune system: Bcl-2, BH3-Only proteins and more. Annu. Rev. Immunol. 21 71-105.
38. P. Matzinger (1994) Tolerance, danger and the extended family. Annu. Rev. Immunol. 12 991-1045.
39. T.L. McGaha, B. Sorrentino and J.V. Ravetch (2005) Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 307 590-593.
40. J.F.A.P. Miller (1961) Immunological function of the thymus. Lancet 2 748-749.
41. J.F.A.P. Miller (1971) The thymus in immunity. Rec. Austral. Acad. Sci. 2 82-98.
42. G.F. Mitchell and J.F.A.P. Miller (1968) Cell to cell interaction in the immune response II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J. Exp. Med. 128 821-837.
43. M. Murakami, T. Tsubata, M. Okamoto, A. Shimizu, S. Kumagai, H. Imura and T. Honjo (1992) Antigen induced apoptotic death of Ly-1B cells responsible for autoimmune disease in transgenic mice. Nature 357 77-80.
44. D.A. Nemazee and K. Bürki (1989) Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337 562-566.
45. D.S. Nieves, R.P. Phipps, S.J. Pollock, H.D. Ochs, Q.L. Zhu, G.A. Scott, C.K. Ryan, I. Kobayashi, T.M. Rossi and L.A. Goldsmith (2004) Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch. Dermatol. 140 466-472.
46. G.J.V. Nossal (1957) The immunological response of foetal mice to influenza virus. Austral. J. Exp. Biol. 35 549.
47. G.J.V. Nossal (1983) Cellular mechanisms of immunologic tolerance. Annu. Rev. Immunol. 1 33-62.
48. G.J.V. Nossal (1992) Cellular and molecular mechanisms of B lymphocyte tolerance. Adv. Immunol. 52 283-331.
49. G.J.V. Nossal and B.L. Pike (1980) Clonal anergy: Persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen. Proc. Natl. Acad. Sci. USA 70 1602-1606.
50. D.G. Osmond (1991) Proliferation kinetics and the life span of B cells in central and peripheral lymphoid organs. Curr. Opin. Immunol. 3 179-185.
51. R.D. Owen (1945) Immunogentic consequences of vascular anastomoses between bovine twins. Science 102 400-401.
52. C.R. Parish (1972) The relationship between humoral and cell mediated immunity. Trans. Rev. 13 35-66.
53. P. Peterson, J. Pitkanen, N. Sillanpaa and K. Krohn (2004) Autoimmune polyendocrinopathy candidiases ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity. Clin. Exp. Immunol. 135 348-357.
54. T.G. Phan, M. Amesbury, S. Gardam, J. Crosbie, J. Hasbold, P.D. Hodgkin, A. Basten and R.A. Brink (2003) B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J. Exp. Med. 197 845-860.
55. J.C. Rathmell, M.P. Cooke, W.Y. Ho, J. Grein, S.E. Townsend, M.M. Davis and C.C. Goodnow (1995) CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376 181-184.
56. F. Rieux-Laucat, F. Le Deist and A. Fischer (2003) Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Diff. 10 124-133.
57. D.M. Russell, Z. Dembic, G. Morahan, J.F.A.P. Miller, K. Bürki and D. Nemazee (1991) Peripheral deletion of self-reactive B cells. Nature 354 308-311.
58. R.H. Schwartz (1993) Immunological tolerance. W.E. Paul (Eds) Fundamental Immunology 3rd ed. New York: Raven 677-732.
59. P.A. Silveira, J. Dombrowsky, E. Johnson, H.D. Chapman, D. Nemazee and D.V. Serreze (2004) B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J. Immunol. 172 5086-5094.
60. M. Thien, T.G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay and R. Brink (2004) Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20 785-798.
61. G. Thyphronitis, T. Kinoshita, K. Inoue, J.E. Schweinle, G.C. Tsokos, E.S. Metcalf, F.D. Finkelman and J.E. Balow (1991) Modulation of mouse complement receptor 1 and receptor 2 suppresses antibody responses in vivo. J. Immunol. 147 224-230.
62. S.L. Tiegs, D.M. Russell and D.A. Namazee (1993) Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177 1009-1020.
63. E. Traub (1938) Factors influencing the persistence of choriomeningitis virus in the blood of mice after clinical recovery. J. Exp. Med. 68 229-250.
64. C.G. Vinuesa and C.C. Goodnow (2002) Immunology: DNA drives autoimmunity. Nature 416 595-598.
65. H. Wardemann, S. Yurasov, A. Schaefer, J.W. Young, E. Meffre and M.C. Nussenzweig (2003) Predominant autoantibody production by early human B cell precursors. Science 301 1374-1377.
66. R.M. Zinkernagel and P.C. Doherty (1974) Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature (London) 248 701-702.